Half Year Results Investor Presentation
Arecor Therapeutics plc will host a live investor presentation on Monday, October 12th at 14:00 BST to discuss their half-year results for the six months ending June 30, 2026. The presentation, accessible via the Investor Meet Company platform, is open to all shareholders and potential investors, with questions able to be submitted in advance or during the event. This announcement provides an opportunity for stakeholders to gain insights into the company's financial performance and strategic developments.
Select text to share a quote on X · sign in to keep highlights & notes in your AREC notes
Cambridge, UK, 8 October 2026: Arecor Therapeutics plc (AIM: AREC), a clinical stage biotech company developing superior therapeutics that can reduce treatment burden and improve outcomes for people living with diabetes, obesity and other cardiometabolic diseases, announces that Sarah Howell, Chief Executive Officer, and David Ellam, Chief Financial Officer, will be providing a live presentation of the Group's recently announced half year results for the six months to 30 June 2026 via the Investor Meet Company platform on Monday 12 October at 14:00 BST.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 11 October, 09:00 BST, or at any time during the live presentation.
To sign up to Investor Meet Company for free and to register for Arecor's presentation, please visit:
Investors who already follow Arecor on the Investor Meet Company platform will automatically be invited to the event.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.